九强生物(300406)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300406 九强生物

已收盘 05-15 15:00:00

{"stockData":{"symbol":"300406","market":"SZ","secType":"STK","nameCN":"九强生物","latestPrice":17.63,"timestamp":1715756586000,"preClose":17.81,"halted":0,"volume":2030500,"delay":0,"floatShares":422000000,"shares":588000000,"eps":0.9065,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.18,"latestTime":"05-15 15:00:00","open":17.88,"high":17.88,"low":17.5,"amount":35912400,"amplitude":0.0213,"askPrice":17.64,"askSize":56,"bidPrice":17.63,"bidSize":76,"shortable":0,"etf":0,"ttmEps":0.9065,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715823000000},"adr":0,"adjPreClose":17.81,"symbolType":"stock","openAndCloseTimeList":[[1715736600000,1715743800000],[1715749200000,1715756400000]],"highLimit":19.59,"lowLimit":16.03,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":588446253,"pbRate":2.85,"roa":"--","roe":"3.19%","epsLYR":0.9,"committee":-0.28423,"marketValue":10374000000,"floatMarketCap":7446000000,"peRate":19.448428,"changeRate":-0.0101,"turnoverRate":0.0048,"status":1},"requestUrl":"/m/hq/s/300406","defaultTab":"news","newsList":[{"id":"2433546012","title":"中泰证券：给予九强生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2433546012","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433546012?lang=zh_cn&edition=full","pubTime":"2024-05-06 10:45","pubTimestamp":1714963559,"startTime":"0","endTime":"0","summary":"中泰证券股份有限公司谢木青,祝嘉琦,于佳喜近期对九强生物进行研究并发布了研究报告《政策影响下业绩稳健，持续看好病理业务+国改赋能》，本报告对九强生物给出买入评级，当前股价为18.95元。公司当前股价对应2024-2026年约18、15、11倍PE，考虑公司生化、血凝业务趋势向上，病理赛道持续高景气，化学发光等新产品有望快速放量，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级3家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050600005710.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431168868","title":"九强生物新注册《MDC7500全自动凝血分析仪操作软件V1.1.2.000051》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2431168868","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431168868?lang=zh_cn&edition=full","pubTime":"2024-04-30 01:10","pubTimestamp":1714410625,"startTime":"0","endTime":"0","summary":"证券之星消息，近日九强生物（300406）新注册了《MDC7500全自动凝血分析仪操作软件V1.1.2.000051》项目的软件著作权。今年以来九强生物新注册软件著作权2个。结合公司2023年年报财务数据，2023年公司在研发方面投入了1.63亿元，同比增18.73%。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000001035.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430051773","title":"九强生物最新公告：一季度净利润1.21亿元 同比增长8.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430051773","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430051773?lang=zh_cn&edition=full","pubTime":"2024-04-28 20:30","pubTimestamp":1714307457,"startTime":"0","endTime":"0","summary":"九强生物发布2024年一季度报告，报告期内实现营业收入3.94亿元，同比增长5.49%。归属于上市公司股东的净利润1.21亿元，同比增长8.67%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800009103.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430031088","title":"图解九强生物一季报：第一季度单季净利润同比增8.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430031088","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430031088?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:46","pubTimestamp":1714297602,"startTime":"0","endTime":"0","summary":"证券之星消息，九强生物2024年一季报显示，公司主营收入3.94亿元，同比上升5.49%；归母净利润1.21亿元，同比上升8.67%；扣非净利润1.21亿元，同比上升10.91%；负债率27.2%，投资收益111.52万元，财务费用1065.96万元，毛利率76.86%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800006478.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430316500","title":"九强生物(300406.SZ)发布一季度业绩，净利润1.21亿元，增长8.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430316500","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430316500?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:42","pubTimestamp":1714297350,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布2024年一季度报告，报告期内实现营业收入3.94亿元，同比增长5.49%。归属于上市公司股东的净利润1.21亿元，同比增长8.67%。归属于上市公司股东的扣除非经常性损益的净利润1.21亿元，同比增长10.91%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1113416.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430778984","title":"九强生物新注册《Gi1600全自动化学发光免疫分析仪操作软件V1.2.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2430778984","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430778984?lang=zh_cn&edition=full","pubTime":"2024-04-27 01:25","pubTimestamp":1714152348,"startTime":"0","endTime":"0","summary":"证券之星消息，近日九强生物（300406）新注册了《Gi1600全自动化学发光免疫分析仪操作软件V1.2.0》项目的软件著作权。今年以来九强生物新注册软件著作权1个。结合公司2023年年报财务数据，2023年公司在研发方面投入了1.63亿元，同比增18.73%。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042700002419.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2423662204","title":"九强生物(300406.SZ)发布2023年度业绩，净利润5.24亿元，增长34.60%，拟10股派2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2423662204","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2423662204?lang=zh_cn&edition=full","pubTime":"2024-03-29 20:39","pubTimestamp":1711715940,"startTime":"0","endTime":"0","summary":"九强生物发布2023年年度报告，该公司营业收入为17.42亿元，同比增长15.27%。归属于上市公司股东的净利润为5.24亿元，同比增长34.60%。基本每股收益为0.9元。报告期内，医疗机构需求恢复，门诊及手术量全面恢复，带动生化及病理试剂销售增长。与此同时公司不断加大市场开拓力度，拓展销售渠道，寻求新的经济增长点。同时，以市场为导向，进一步加大研发投入，不断创新产品，丰富产品结构。此外，拟向全体股东每10股派发现金红利2元(含税)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-29/doc-inapyyaq1167458.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-29/doc-inapyyaq1167458.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2014-10-30","address":"北京市海淀区花园东路15号旷怡大厦5层","stockEarnings":[{"period":"1week","weight":-0.0501},{"period":"1month","weight":0.0107},{"period":"3month","weight":-0.0909},{"period":"6month","weight":-0.0537},{"period":"1year","weight":-0.2046},{"period":"ytd","weight":-0.0671}],"companyName":"北京九强生物技术股份有限公司","boardCode":"AI0027","perCapita":"32027股","boardName":"医药制造业","registeredCapital":"58844万元","compareEarnings":[{"period":"1week","weight":-0.0027},{"period":"1month","weight":0.0204},{"period":"3month","weight":0.0886},{"period":"6month","weight":0.0215},{"period":"1year","weight":-0.052},{"period":"ytd","weight":0.0487}],"survey":"　　北京九强生物技术股份有限公司主营业务是生化诊断、血凝检测、血型检测和肿瘤病理诊断的研发、生产和销售。主要产品包括胱抑素C、同型半胱氨酸、胆汁酸（TBA）、载脂蛋白A1、载脂蛋白B、小而密低密度脂蛋白胆固醇、肌酸激酶同工酶（mass法）等生化诊断试剂。2023年2月22日，2022年（第29批）新认定国家企业技术中心名单及全部国家企业技术中心名单公布，公司成功入选，荣获“国家企业技术中心”认定。","serverTime":1715800680632,"listedPrice":14.32,"stockholders":"13186人(较上一季度增加2.43%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九强生物(300406)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九强生物(300406)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九强生物,300406,九强生物股票,九强生物股票老虎,九强生物股票老虎国际,九强生物行情,九强生物股票行情,九强生物股价,九强生物股市,九强生物股票价格,九强生物股票交易,九强生物股票购买,九强生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九强生物(300406)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九强生物(300406)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}